Ketorolac Tromethamine Dosing for 11-Year-Old Female
For an 11-year-old female child, administer ketorolac tromethamine at 0.5 mg/kg intravenously, with a maximum single dose of 30 mg for intraoperative use, or 0.15-0.2 mg/kg (maximum 10 mg) every 6 hours for short-term postoperative therapy (maximum 48 hours). 1
Dosing Algorithm
Initial/Intraoperative Dose:
- 0.5-1 mg/kg IV up to a maximum of 30 mg as a single intraoperative dose 1
Postoperative Maintenance Dosing:
- 0.15-0.2 mg/kg IV (maximum 10 mg per dose) every 6 hours
- Maximum duration: 48 hours 1
Evidence-Based Rationale
The 2024 ESPA (European Society for Paediatric Anaesthesiology) guidelines provide the most current and authoritative dosing recommendations for pediatric ketorolac 1. These guidelines distinguish between higher single intraoperative doses and lower maintenance doses for postoperative pain management.
The FDA label confirms that pediatric pharmacokinetic data support 0.5 mg/kg dosing in children aged 4-8 years, with a half-life of 5.8 ± 1.6 hours and clearance of 0.042 ± 0.01 L/hr/kg 2. An 11-year-old falls within the age range where this dosing maintains therapeutic concentrations.
Research evidence supports that 0.5 mg/kg every 6 hours maintains trough concentrations above the therapeutic threshold (0.37 mg/L) in children aged 9 months to 16 years 3. Multiple studies confirm that weight-normalized pharmacokinetic parameters in children aged 1-16 years are similar to adults, with no evidence that children require larger weight-adjusted doses or shorter dosing intervals 4.
Critical Safety Considerations
Maximum Dose Caps:
- Intraoperative single dose: 30 mg maximum 1
- Postoperative repeated doses: 10 mg maximum per dose 1
- Total duration: Do not exceed 48 hours 1
Important Caveats:
Renal function: Ketorolac is contraindicated in patients with renal impairment. The drug is 92% renally excreted, and clearance decreases significantly with renal dysfunction 2. Always verify normal renal function before administration.
Bleeding risk: While ketorolac has reversible antiplatelet effects, avoid in patients with coagulopathy or high bleeding risk procedures (particularly tonsillectomy, where evidence is conflicting) 5.
Concurrent medications: Contraindicated with probenecid (increases ketorolac levels 3-fold). Use caution with ACE inhibitors, diuretics, SSRIs, and other NSAIDs 2.
Practical Application for an 11-Year-Old
Assuming a typical 11-year-old female weighs approximately 35-40 kg:
Intraoperative dose: 0.5 mg/kg × 35 kg = 17.5 mg (round to 15-20 mg, well below 30 mg cap)
Postoperative dose: 0.15-0.2 mg/kg × 35 kg = 5.25-7 mg every 6 hours (well below 10 mg cap)
Recent evidence suggests that lower doses may be equally effective with potentially fewer adverse effects 6, 7, supporting the conservative postoperative dosing strategy recommended in the ESPA guidelines.
The distinction between higher intraoperative and lower postoperative dosing reflects the balance between achieving adequate analgesia and minimizing cumulative NSAID exposure and associated risks 1.